These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 17013910)

  • 21. Valproate-induced parkinsonism: use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an "old" drug.
    Hauben M; Reich L
    Mov Disord; 2005 Mar; 20(3):387. PubMed ID: 15641014
    [No Abstract]   [Full Text] [Related]  

  • 22. Parkinsonism after chronic occupational exposure to glyphosate.
    Wang G; Fan XN; Tan YY; Cheng Q; Chen SD
    Parkinsonism Relat Disord; 2011 Jul; 17(6):486-7. PubMed ID: 21367645
    [No Abstract]   [Full Text] [Related]  

  • 23. First Report of Parkinsonism Associated With Indoximod, an Immune-Modulating Agent.
    Floyd M; El Osta B; Tang SC
    J Glob Oncol; 2018 Sep; 4():1-2. PubMed ID: 30241153
    [No Abstract]   [Full Text] [Related]  

  • 24. What is the risk of developing parkinsonism following neuroleptic use?
    Noyes K; Liu H; Holloway RG
    Neurology; 2006 Mar; 66(6):941-3. PubMed ID: 16567720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy and diagnosis of patients with drug-induced parkinsonism].
    Yamamoto T
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1467-71. PubMed ID: 13677896
    [No Abstract]   [Full Text] [Related]  

  • 26. Quetiapine use in a patient with chronic schizophrenia and severe parkinsonism.
    Stoner SC; Lea JW; Wolf AL; Berges AA
    Pharmacotherapy; 2005 Nov; 25(11):1651-5. PubMed ID: 16232027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Essential points to differentiate various diseases causing parkinsonism].
    Naito Y; Kuzuhara S
    Nihon Rinsho; 2004 Sep; 62(9):1608-16. PubMed ID: 15462373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible parkinsonism and ataxia associated with high-dose octreotide.
    Espay AJ
    Neurology; 2008 Jun; 70(24):2345-6. PubMed ID: 18463367
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug-induced parkinsonism].
    Shiio Y
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():377-81. PubMed ID: 18072346
    [No Abstract]   [Full Text] [Related]  

  • 30. Valproate-induced parkinsonism, glial cells and Alexander's disease.
    Sechi GP; Conti M; Sau GF; Cocco GA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1351-2. PubMed ID: 18495313
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug-induced Parkinsonism].
    López Pardo P
    Rev Esp Geriatr Gerontol; 2019; 54(3):181-183. PubMed ID: 30770215
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolonged residual catatonia or prolonged neuroleptic-induced Parkinsonism following catatonic stupor in a patient with manic-depressive illness.
    Suzuki K; Takano T; Ito K; Ebina Y; Matsuoka H; Awata S
    Mov Disord; 2007 Jan; 22(1):152-3. PubMed ID: 17080430
    [No Abstract]   [Full Text] [Related]  

  • 33. Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature.
    Mahmoud F; Tampi RR
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):405-12. PubMed ID: 21993183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drugs induced Parkinsonism: the case of a 77 year old woman].
    Arzur J; De la Gastine B; Bessodes A; Coquerel A
    Rev Med Interne; 2006 May; 27(5):422-4. PubMed ID: 16360242
    [No Abstract]   [Full Text] [Related]  

  • 35. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases.
    Masmoudi K; Gras-Champel V; Masson H; Andréjak M
    Pharmacopsychiatry; 2006 Jan; 39(1):9-12. PubMed ID: 16453247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome p450 and parkinsonism: protective role of CYP2E1.
    Vaglini F; Pardini C; Viaggi C; Corsini GU
    Funct Neurol; 2001; 16(4 Suppl):107-12. PubMed ID: 11996504
    [No Abstract]   [Full Text] [Related]  

  • 37. Parkinsonian signs in subjects with mild cognitive impairment.
    Boyle PA; Wilson RS; Aggarwal NT; Arvanitakis Z; Kelly J; Bienias JL; Bennett DA
    Neurology; 2005 Dec; 65(12):1901-6. PubMed ID: 16380610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient.
    Saddichha S; Kumar R; Babu GN; Chandra P
    J Clin Pharmacol; 2012 Sep; 52(9):1448-9. PubMed ID: 21903892
    [No Abstract]   [Full Text] [Related]  

  • 39. Patient with parkinsonism and a history of methanol toxicity.
    Enriquez-Marulanda A; Ospina-Delgado D; Arias-Mora F; Amaya-González P; Orozco JL
    Neurologia (Engl Ed); 2019 Oct; 34(8):555-556. PubMed ID: 28108118
    [No Abstract]   [Full Text] [Related]  

  • 40. Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms.
    López-Torres E; Salomón J; Vicario F; Peñas-Lledó E; Dorado P; Llerena A
    J Clin Psychopharmacol; 2008 Jun; 28(3):352-3. PubMed ID: 18480698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.